Loading…
Reported covered position: Deputy Health Policy Director, U.S. Senate Committee on Health, Education, Labor and Pensions (HELP); Deputy Chief Health Counsel and Director of Coalitions, U.S. House Committee on Energy and Commerce; Covered Official Positions Continued: Deputy Chief of Staff, U.S. Rep. Markwayne Mullin (R-OK); Communications Director & Legislative Assistant, U.S. Rep. Gregg Harper (R-MS)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to health care data, technology, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. S.3018/H.R.3173: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Issues related to health care data, technology, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. S.3018/H.R.3173: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BLOOD CANCER UNITED via ALB SOLUTIONS
2026 · third_quarter · Q3
Hospital competition and site-neutral payment reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED via ALB SOLUTIONS
2026 · second_quarter · 2A
Source: Senate LDA
| AMERICAN HEART ASSOCIATION |
| 14 |
| 2023–2026 |
| BETTER SOLUTIONS FOR HEALTHCARE | 14 | 2023–2026 |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | 12 | 2024–2026 |
| MARIUS PHARMACEUTICALS LLC | 9 | 2022–2024 |
| NOVAVAX, INC. | 9 | 2021–2022 |
| CENTENE CORPORATIONS | 8 | 2025–2026 |
| OLIVE AI | 5 | 2022 |
| AIS HEALTHCARE | 4 | 2026 |
| CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATES | 4 | 2026 |
| INDEPENDENCE BLUE CROSS | 4 | 2026 |
| SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION | 4 | 2026 |
| VERTEX PHARMACEUTICALS | 4 | 2026 |
| FARRAGUT PARTNERS LLP ON BEHALF OF JOHNSON & JOHNSON SERVICES INC. | 3 | 2021 |
Issues related to health care data, technology, price transparency, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. H.R.3173: Improving Seniors Timely Access to Care Act of 2021. S.3018: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Issues related to health care data, technology, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. S.3018/H.R.3173: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Issues related to health care data, technology, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. S.3018/H.R.3173: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Issues related to health care data, technology, price transparency, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. H.R.3173: Improving Seniors Timely Access to Care Act of 2021. S.3018: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Issues related to health care data, technology, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. S.3018/H.R.3173: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Issues related to health care data, technology, price transparency, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. H.R.3173: Improving Seniors Timely Access to Care Act of 2021. S.3018: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Issues related to health care data, technology, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. S.3018/H.R.3173: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Issues related to health care data, technology, price transparency, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. H.R.3173: Improving Seniors Timely Access to Care Act of 2021. S.3018: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Issues related to health care data, technology, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. S.3018/H.R.3173: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Issues related to health care data, technology, prior authorization, and interoperability. H.R.7995: GOLD CARD Act of 2022. S.3018/H.R.3173: Improving Seniors Timely Access to Care Act of 2021. H.R.8152: American Data Privacy and Protection Act.
Dr. Lorna Breen Health Care Provider Protection Act
Client: FARRAGUT PARTNERS LLP ON BEHALF OF JOHNSON & JOHNSON SERVICES INC. · Firm: ALB SOLUTIONS
Issues related to H.R.1667: Dr. Lorna Breen Health Care Provider Protection Act.
Dr. Lorna Breen Health Care Provider Protection Act
Client: FARRAGUT PARTNERS LLP ON BEHALF OF JOHNSON & JOHNSON SERVICES INC. · Firm: ALB SOLUTIONS
Issues related to H.R.1667: Dr. Lorna Breen Health Care Provider Protection Act.
Dr. Lorna Breen Health Care Provider Protection Act
Client: FARRAGUT PARTNERS LLP ON BEHALF OF JOHNSON & JOHNSON SERVICES INC. · Firm: ALB SOLUTIONS
Issues related to H.R.1667: Dr. Lorna Breen Health Care Provider Protection Act.
Vaccine policy issues and COVID-19 related activity. H.R. 3788: To establish limitations on modifications to trade agreements, and for other purposes. H.R.3656: Vaccine Access Improvement Act of 2021.
Vaccine policy issues and COVID-19 related activity. H.R. 3788: To establish limitations on modifications to trade agreements, and for other purposes. H.R.3656: Vaccine Access Improvement Act of 2021.
Vaccine policy issues and COVID-19 related activity. H.R. 3788: To establish limitations on modifications to trade agreements, and for other purposes.
Vaccine policy issues and COVID-19 related activity. H.R. 3788: To establish limitations on modifications to trade agreements, and for other purposes. H.R.3656: Vaccine Access Improvement Act of 2021.
Vaccine policy issues and COVID-19 related activity. H.R. 3788: To establish limitations on modifications to trade agreements, and for other purposes.
Vaccine policy issues and COVID-19 related activity. H.R. 3788: To establish limitations on modifications to trade agreements, and for other purposes. H.R.3656: Vaccine Access Improvement Act of 2021.
Hospital competition and site-neutral payment reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED via ALB SOLUTIONS
2026 · first_quarter · 1A
Hospital competition and site-neutral payment reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS via ALB SOLUTIONS
2026 · third_quarter · Q3
Non-opioid pain relief and drug pipeline issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION via ALB SOLUTIONS
2026 · third_quarter · Q3
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INDEPENDENCE BLUE CROSS via ALB SOLUTIONS
2026 · third_quarter · Q3
Health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
HUMANA, INC. via ALB SOLUTIONS
2026 · third_quarter · Q3
Issues related to health care payment policy, including Medicare Advantage, Medicare Part D and other payer policy matters, as well as health care clinical services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. via ALB SOLUTIONS
2026 · third_quarter · Q3
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CVS HEALTH (AND SUBSIDIARIES) via ALB SOLUTIONS
2026 · third_quarter · Q3
Health care policy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATES via ALB SOLUTIONS
2026 · third_quarter · Q3
Issues related to health care policy including coverage and cost of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATIONS via ALB SOLUTIONS
2026 · third_quarter · Q3
Issues related to health care policy including coverage and cost of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAREVISO INC. via ALB SOLUTIONS
2026 · third_quarter · Q3
Health care transparency issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via ALB SOLUTIONS
2026 · third_quarter · Q3
Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via ALB SOLUTIONS
2026 · third_quarter · Q3
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BETTER SOLUTIONS FOR HEALTHCARE via ALB SOLUTIONS
2026 · third_quarter · Q3
Promote hospital competition, enforce federal price transparency laws for hospital charges, rein in hospital price markups, and ensure honest billing practices by hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSOCIATION via ALB SOLUTIONS
2026 · third_quarter · Q3
HEARTS Act funding and legislative proposals that align with the associations mission of building healthier lives, free of cardiovascular diseases and stroke.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIS HEALTHCARE via ALB SOLUTIONS
2026 · third_quarter · Q3
Issues related to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
VERTEX PHARMACEUTICALS via ALB SOLUTIONS
2026 · second_quarter · Q2
Non-opioid pain relief and drug pipeline issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION via ALB SOLUTIONS
2026 · second_quarter · Q2
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INDEPENDENCE BLUE CROSS via ALB SOLUTIONS
2026 · second_quarter · Q2
Health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
HUMANA, INC. via ALB SOLUTIONS
2026 · second_quarter · Q2
Issues related to health care payment policy, including Medicare Advantage, Medicare Part D and other payer policy matters, as well as health care clinical services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. via ALB SOLUTIONS
2026 · second_quarter · Q2
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CVS HEALTH (AND SUBSIDIARIES) via ALB SOLUTIONS
2026 · second_quarter · Q2
Health care policy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATES via ALB SOLUTIONS
2026 · second_quarter · Q2
Issues related to health care policy including coverage and cost of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATIONS via ALB SOLUTIONS
2026 · second_quarter · Q2
Issues related to health care policy including coverage and cost of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAREVISO INC. via ALB SOLUTIONS
2026 · second_quarter · Q2
Health care transparency issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via ALB SOLUTIONS
2026 · second_quarter · Q2
Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via ALB SOLUTIONS
2026 · second_quarter · Q2
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BLOOD CANCER UNITED via ALB SOLUTIONS
2026 · second_quarter · Q2
Hospital competition and site-neutral payment reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BETTER SOLUTIONS FOR HEALTHCARE via ALB SOLUTIONS
2026 · second_quarter · Q2
Promote hospital competition, enforce federal price transparency laws for hospital charges, rein in hospital price markups, and ensure honest billing practices by hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSOCIATION via ALB SOLUTIONS
2026 · second_quarter · Q2
HEARTS Act funding and legislative proposals that align with the associations mission of building healthier lives, free of cardiovascular diseases and stroke.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIS HEALTHCARE via ALB SOLUTIONS
2026 · second_quarter · Q2
Issues related to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATES via ALB SOLUTIONS
2026 · first_quarter · Q1
Issues related to health care policy including coverage and cost of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATES via ALB SOLUTIONS
2026 · first_quarter · RR
Issues related to health care policy including coverage and cost of care.
VERTEX PHARMACEUTICALS via ALB SOLUTIONS
2026 · first_quarter · Q1
Non-opioid pain relief and drug pipeline issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION via ALB SOLUTIONS
2026 · first_quarter · Q1
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INDEPENDENCE BLUE CROSS via ALB SOLUTIONS
2026 · first_quarter · Q1
Health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
HUMANA, INC. via ALB SOLUTIONS
2026 · first_quarter · Q1
Issues related to health care payment policy, including Medicare Advantage, Medicare Part D and other payer policy matters, as well as health care clinical services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. via ALB SOLUTIONS
2026 · first_quarter · Q1
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CVS HEALTH (AND SUBSIDIARIES) via ALB SOLUTIONS
2026 · first_quarter · Q1
Health care policy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATIONS via ALB SOLUTIONS
2026 · first_quarter · Q1
Issues related to health care policy including coverage and cost of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAREVISO INC. via ALB SOLUTIONS
2026 · first_quarter · Q1
Health care transparency issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via ALB SOLUTIONS
2026 · first_quarter · Q1
Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via ALB SOLUTIONS
2026 · first_quarter · Q1
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BLOOD CANCER UNITED via ALB SOLUTIONS
2026 · first_quarter · Q1
Hospital competition and site-neutral payment reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BETTER SOLUTIONS FOR HEALTHCARE via ALB SOLUTIONS
2026 · first_quarter · Q1
Promote hospital competition, enforce federal price transparency laws for hospital charges, rein in hospital price markups, and ensure honest billing practices by hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSOCIATION via ALB SOLUTIONS
2026 · first_quarter · Q1
HEARTS Act funding and legislative proposals that align with the associations mission of building healthier lives, free of cardiovascular diseases and stroke.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIS HEALTHCARE via ALB SOLUTIONS
2026 · first_quarter · Q1
Issues related to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
VERTEX PHARMACEUTICALS via ALB SOLUTIONS
2026 · first_quarter · RR
Non-opioid pain relief and drug pipeline issues.
INDEPENDENCE BLUE CROSS via ALB SOLUTIONS
2026 · first_quarter · RR
Health care payment policy.
AIS HEALTHCARE via ALB SOLUTIONS
2026 · first_quarter · RR
Issues related to opioids public policy.
SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION via ALB SOLUTIONS
2026 · first_quarter · RR
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.
BLOOD CANCER UNITED via ALB SOLUTIONS
2025 · fourth_quarter · Q4
Hospital competition and site-neutral payment reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMANA, INC. via ALB SOLUTIONS
2025 · fourth_quarter · Q4
Issues related to health care payment policy, including Medicare Advantage, Medicare Part D and other payer policy matters, as well as health care clinical services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. via ALB SOLUTIONS
2025 · fourth_quarter · Q4
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CVS HEALTH (AND SUBSIDIARIES) via ALB SOLUTIONS
2025 · fourth_quarter · Q4
Health care policy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATIONS via ALB SOLUTIONS
2025 · fourth_quarter · Q4
Issues related to health care policy including coverage and cost of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAREVISO INC. via ALB SOLUTIONS
2025 · fourth_quarter · Q4
Health care transparency issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via ALB SOLUTIONS
2025 · fourth_quarter · Q4
Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via ALB SOLUTIONS
2025 · fourth_quarter · Q4
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BETTER SOLUTIONS FOR HEALTHCARE via ALB SOLUTIONS
2025 · fourth_quarter · Q4
Promote hospital competition, enforce federal price transparency laws for hospital charges, rein in hospital price markups, and ensure honest billing practices by hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSOCIATION via ALB SOLUTIONS
2025 · fourth_quarter · Q4
HEARTS Act funding and legislative proposals that align with the associations mission of building healthier lives, free of cardiovascular diseases and stroke.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED via ALB SOLUTIONS
2025 · third_quarter · Q3
Hospital competition and site-neutral payment reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMANA, INC. via ALB SOLUTIONS
2025 · third_quarter · Q3
Issues related to health care payment policy, including Medicare Advantage, Medicare Part D and other payer policy matters, as well as health care clinical services. PL 119-21: One Big Beautiful Bill Act.
PL 119-21: One Big Beautiful Bill Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. via ALB SOLUTIONS
2025 · third_quarter · Q3
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH (AND SUBSIDIARIES) via ALB SOLUTIONS
2025 · third_quarter · Q3
Health care policy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATIONS via ALB SOLUTIONS
2025 · third_quarter · Q3
Issues related to health care policy including coverage and cost of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAREVISO INC. via ALB SOLUTIONS
2025 · third_quarter · Q3
Health care transparency issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via ALB SOLUTIONS
2025 · third_quarter · Q3
Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via ALB SOLUTIONS
2025 · third_quarter · Q3
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BETTER SOLUTIONS FOR HEALTHCARE via ALB SOLUTIONS
2025 · third_quarter · Q3
Promote hospital competition, enforce federal price transparency laws for hospital charges, rein in hospital price markups, and ensure honest billing practices by hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSOCIATION via ALB SOLUTIONS
2025 · third_quarter · Q3
The Access to AEDs Act, and legislative proposals that align with the associations mission of building healthier lives, free of cardiovascular diseases and stroke.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED via ALB SOLUTIONS
2025 · second_quarter · Q2
Hospital competition and site-neutral payment reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMANA, INC. via ALB SOLUTIONS
2025 · second_quarter · Q2
Issues related to health care payment policy, including Medicare Advantage, Medicare Part D and other payer policy matters, as well as health care clinical services. PL 119-21: One Big Beautiful Bill Act.
PL 119-21: One Big Beautiful Bill Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. via ALB SOLUTIONS
2025 · second_quarter · Q2
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH (AND SUBSIDIARIES) via ALB SOLUTIONS
2025 · second_quarter · Q2
Health care policy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATIONS via ALB SOLUTIONS
2025 · second_quarter · Q2
Issues related to health care policy including coverage and cost of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAREVISO INC. via ALB SOLUTIONS
2025 · second_quarter · Q2
Health care transparency issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via ALB SOLUTIONS
2025 · second_quarter · Q2
Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via ALB SOLUTIONS
2025 · second_quarter · Q2
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BETTER SOLUTIONS FOR HEALTHCARE via ALB SOLUTIONS
2025 · second_quarter · Q2
Promote hospital competition, enforce federal price transparency laws for hospital charges, rein in hospital price markups, and ensure honest billing practices by hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSOCIATION via ALB SOLUTIONS
2025 · second_quarter · Q2
The Access to AEDs Act, and legislative proposals that align with the associations mission of building healthier lives, free of cardiovascular diseases and stroke.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED via ALB SOLUTIONS
2025 · first_quarter · Q1
Hospital competition and site-neutral payment reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMANA, INC. via ALB SOLUTIONS
2025 · first_quarter · Q1
Issues related to health care payment policy, including Medicare Advantage, Medicare Part D and other payer policy matters, as well as health care clinical services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. via ALB SOLUTIONS
2025 · first_quarter · Q1
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH (AND SUBSIDIARIES) via ALB SOLUTIONS
2025 · first_quarter · Q1
Health care policy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATIONS via ALB SOLUTIONS
2025 · first_quarter · Q1
Issues related to health care policy including coverage and cost of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAREVISO INC. via ALB SOLUTIONS
2025 · first_quarter · Q1
Health care transparency issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via ALB SOLUTIONS
2025 · first_quarter · Q1
Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via ALB SOLUTIONS
2025 · first_quarter · Q1
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BETTER SOLUTIONS FOR HEALTHCARE via ALB SOLUTIONS
2025 · first_quarter · Q1
Promote hospital competition, enforce federal price transparency laws for hospital charges, rein in hospital price markups, and ensure honest billing practices by hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSOCIATION via ALB SOLUTIONS
2025 · first_quarter · Q1
The Access to AEDs Act, and legislative proposals that align with the associations mission of building healthier lives, free of cardiovascular diseases and stroke.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATIONS via ALB SOLUTIONS
2025 · first_quarter · RR
Issues related to health care policy including coverage and cost of care.
BLOOD CANCER UNITED FKA THE LEUKEMIA & LYMPHOMA SOCIETY via ALB SOLUTIONS
2024 · fourth_quarter · Q4
Hospital competition and site-neutral payment reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARIUS PHARMACEUTICALS LLC via ALB SOLUTIONS
2024 · fourth_quarter · 4T
Issues related to telehealth. Food and Drug Administration policy issues. Drug Enforcement Administration policy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMANA, INC. via ALB SOLUTIONS
2024 · fourth_quarter · Q4
Issues related to health care payment policy, including Medicare Advantage, Medicare Part D and other payer policy matters, as well as health care clinical services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. via ALB SOLUTIONS
2024 · fourth_quarter · Q4
No Surprises Act implementation and health care payment policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH (AND SUBSIDIARIES) via ALB SOLUTIONS
2024 · fourth_quarter · Q4
Health care policy issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAREVISO INC. via ALB SOLUTIONS
2024 · fourth_quarter · Q4
Health care transparency issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. via ALB SOLUTIONS
2024 · fourth_quarter · Q4
Issues related to regulatory and legislative developments regarding biosimilars and prescription digital therapeutics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE